Upgrade to SI Premium - Free Trial

UPDATE: Regeneron Pharma (REGN) Easily Tops Q4 EPS Views; Guides FY14 EYLEA Sales

February 11, 2014 6:32 AM
(Updated - February 11, 2014 6:53 AM EST)

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) reported Q4 EPS of $2.24, $1.27 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Earnings FDA Guidance Hot Corp. News Hot Earnings Management Comments

Next Articles